Loading…
Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells
The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical inability to inhibit tumor growth. We enumerated with HLA-A*0201/peptide tetramers (tHLA) vaccine-elicited CD8 super(+) T cell precursor frequency among PBMC in 13 patients w...
Saved in:
Published in: | The Journal of immunology (1950) 2002-06, Vol.168 (11), p.5933-5942 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 5942 |
container_issue | 11 |
container_start_page | 5933 |
container_title | The Journal of immunology (1950) |
container_volume | 168 |
creator | Monsurro, V Nagorsen, D Wang, E Provenzano, M Dudley, ME Rosenberg, SA Marincola, F M |
description | The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical inability to inhibit tumor growth. We enumerated with HLA-A*0201/peptide tetramers (tHLA) vaccine-elicited CD8 super(+) T cell precursor frequency among PBMC in 13 patients with melanoma undergoing vaccination with the HLA-A*0201-associated gp100:209 217(210 M) epitope. T cell precursor frequency increased from undetectable to 12,400 plus or minus 3,600 x 10 CD8 super(+) T cells after vaccination and appeared heterogeneous according to previously described functional subtypes: CD45RA super(+)CD27 super(+) (14 plus or minus 2.6% of tHLA-staining T cells), naive; CD45RA super(-)CD27 super(+) (14 plus or minus 3.2%), memory; CD45RA super(+)CD27 super(-) (43 plus or minus 6%), effector; and CD45RA super(-)CD27 super(-) (30 plus or minus 4.1%), memory/effector. The majority of tHLA super(+)CD8 super(+) T cells displayed an effector, CD27 super(-) phenotype (73%). However, few expressed perforin (17%). Epitope-specific in vitro stimulation (IVS) followed by 10-day expansion in IL-2 reversed this phenotype by increasing the number of perforin super(+) (84 plus or minus 3.6%; by paired t test, p < 0.001) and CD27 super(+) (from 28 to 67%; by paired t test, p = 0.01) tHLA super(+) T cells. This conversion probably represented a change in the functional status of tHLA super(+) T cells rather than a preferential expansion of a CD27 super(+) (naive and/or memory) PBMC, because it was reproduced after IVS of a T cell clone bearing a classic effector phenotype (CD45RA super(+)CD27 super(-)). These findings suggest that circulating vaccine-elicited T cells are not as functionally active as inferred by characterization of IVS-induced CTL. In addition, CD45RA/CD27 expression may be more informative about the status of activation of circulating T cells than their status of differentiation. |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_18398694</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18398694</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_183986943</originalsourceid><addsrcrecordid>eNqNyrsKwjAUANAMCtbHP9xJFCmkD_rYhGqpe-laQnorkZjU3mTw73XwA5zOchYs4DyOwyjP8hVbEz045xmP04Cda2-kU9YIDQ06nO0dDSr3BjtCJ6RUBsObGbzEAapLAeQnnA-nI7RQoda0ZctRaMLdzw3b19e2asJpti-P5PqnIvmdwqD11EdFUhZZmSZ_xw-4RjpL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18398694</pqid></control><display><type>article</type><title>Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells</title><source>EZB Electronic Journals Library</source><creator>Monsurro, V ; Nagorsen, D ; Wang, E ; Provenzano, M ; Dudley, ME ; Rosenberg, SA ; Marincola, F M</creator><creatorcontrib>Monsurro, V ; Nagorsen, D ; Wang, E ; Provenzano, M ; Dudley, ME ; Rosenberg, SA ; Marincola, F M</creatorcontrib><description>The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical inability to inhibit tumor growth. We enumerated with HLA-A*0201/peptide tetramers (tHLA) vaccine-elicited CD8 super(+) T cell precursor frequency among PBMC in 13 patients with melanoma undergoing vaccination with the HLA-A*0201-associated gp100:209 217(210 M) epitope. T cell precursor frequency increased from undetectable to 12,400 plus or minus 3,600 x 10 CD8 super(+) T cells after vaccination and appeared heterogeneous according to previously described functional subtypes: CD45RA super(+)CD27 super(+) (14 plus or minus 2.6% of tHLA-staining T cells), naive; CD45RA super(-)CD27 super(+) (14 plus or minus 3.2%), memory; CD45RA super(+)CD27 super(-) (43 plus or minus 6%), effector; and CD45RA super(-)CD27 super(-) (30 plus or minus 4.1%), memory/effector. The majority of tHLA super(+)CD8 super(+) T cells displayed an effector, CD27 super(-) phenotype (73%). However, few expressed perforin (17%). Epitope-specific in vitro stimulation (IVS) followed by 10-day expansion in IL-2 reversed this phenotype by increasing the number of perforin super(+) (84 plus or minus 3.6%; by paired t test, p < 0.001) and CD27 super(+) (from 28 to 67%; by paired t test, p = 0.01) tHLA super(+) T cells. This conversion probably represented a change in the functional status of tHLA super(+) T cells rather than a preferential expansion of a CD27 super(+) (naive and/or memory) PBMC, because it was reproduced after IVS of a T cell clone bearing a classic effector phenotype (CD45RA super(+)CD27 super(-)). These findings suggest that circulating vaccine-elicited T cells are not as functionally active as inferred by characterization of IVS-induced CTL. In addition, CD45RA/CD27 expression may be more informative about the status of activation of circulating T cells than their status of differentiation.</description><identifier>ISSN: 0022-1767</identifier><language>eng</language><ispartof>The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5933-5942</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Monsurro, V</creatorcontrib><creatorcontrib>Nagorsen, D</creatorcontrib><creatorcontrib>Wang, E</creatorcontrib><creatorcontrib>Provenzano, M</creatorcontrib><creatorcontrib>Dudley, ME</creatorcontrib><creatorcontrib>Rosenberg, SA</creatorcontrib><creatorcontrib>Marincola, F M</creatorcontrib><title>Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells</title><title>The Journal of immunology (1950)</title><description>The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical inability to inhibit tumor growth. We enumerated with HLA-A*0201/peptide tetramers (tHLA) vaccine-elicited CD8 super(+) T cell precursor frequency among PBMC in 13 patients with melanoma undergoing vaccination with the HLA-A*0201-associated gp100:209 217(210 M) epitope. T cell precursor frequency increased from undetectable to 12,400 plus or minus 3,600 x 10 CD8 super(+) T cells after vaccination and appeared heterogeneous according to previously described functional subtypes: CD45RA super(+)CD27 super(+) (14 plus or minus 2.6% of tHLA-staining T cells), naive; CD45RA super(-)CD27 super(+) (14 plus or minus 3.2%), memory; CD45RA super(+)CD27 super(-) (43 plus or minus 6%), effector; and CD45RA super(-)CD27 super(-) (30 plus or minus 4.1%), memory/effector. The majority of tHLA super(+)CD8 super(+) T cells displayed an effector, CD27 super(-) phenotype (73%). However, few expressed perforin (17%). Epitope-specific in vitro stimulation (IVS) followed by 10-day expansion in IL-2 reversed this phenotype by increasing the number of perforin super(+) (84 plus or minus 3.6%; by paired t test, p < 0.001) and CD27 super(+) (from 28 to 67%; by paired t test, p = 0.01) tHLA super(+) T cells. This conversion probably represented a change in the functional status of tHLA super(+) T cells rather than a preferential expansion of a CD27 super(+) (naive and/or memory) PBMC, because it was reproduced after IVS of a T cell clone bearing a classic effector phenotype (CD45RA super(+)CD27 super(-)). These findings suggest that circulating vaccine-elicited T cells are not as functionally active as inferred by characterization of IVS-induced CTL. In addition, CD45RA/CD27 expression may be more informative about the status of activation of circulating T cells than their status of differentiation.</description><issn>0022-1767</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNyrsKwjAUANAMCtbHP9xJFCmkD_rYhGqpe-laQnorkZjU3mTw73XwA5zOchYs4DyOwyjP8hVbEz045xmP04Cda2-kU9YIDQ06nO0dDSr3BjtCJ6RUBsObGbzEAapLAeQnnA-nI7RQoda0ZctRaMLdzw3b19e2asJpti-P5PqnIvmdwqD11EdFUhZZmSZ_xw-4RjpL</recordid><startdate>20020601</startdate><enddate>20020601</enddate><creator>Monsurro, V</creator><creator>Nagorsen, D</creator><creator>Wang, E</creator><creator>Provenzano, M</creator><creator>Dudley, ME</creator><creator>Rosenberg, SA</creator><creator>Marincola, F M</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20020601</creationdate><title>Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells</title><author>Monsurro, V ; Nagorsen, D ; Wang, E ; Provenzano, M ; Dudley, ME ; Rosenberg, SA ; Marincola, F M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_183986943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monsurro, V</creatorcontrib><creatorcontrib>Nagorsen, D</creatorcontrib><creatorcontrib>Wang, E</creatorcontrib><creatorcontrib>Provenzano, M</creatorcontrib><creatorcontrib>Dudley, ME</creatorcontrib><creatorcontrib>Rosenberg, SA</creatorcontrib><creatorcontrib>Marincola, F M</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monsurro, V</au><au>Nagorsen, D</au><au>Wang, E</au><au>Provenzano, M</au><au>Dudley, ME</au><au>Rosenberg, SA</au><au>Marincola, F M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells</atitle><jtitle>The Journal of immunology (1950)</jtitle><date>2002-06-01</date><risdate>2002</risdate><volume>168</volume><issue>11</issue><spage>5933</spage><epage>5942</epage><pages>5933-5942</pages><issn>0022-1767</issn><abstract>The functional status of circulating vaccine-induced, tumor-specific T cells has been questioned to explain their paradoxical inability to inhibit tumor growth. We enumerated with HLA-A*0201/peptide tetramers (tHLA) vaccine-elicited CD8 super(+) T cell precursor frequency among PBMC in 13 patients with melanoma undergoing vaccination with the HLA-A*0201-associated gp100:209 217(210 M) epitope. T cell precursor frequency increased from undetectable to 12,400 plus or minus 3,600 x 10 CD8 super(+) T cells after vaccination and appeared heterogeneous according to previously described functional subtypes: CD45RA super(+)CD27 super(+) (14 plus or minus 2.6% of tHLA-staining T cells), naive; CD45RA super(-)CD27 super(+) (14 plus or minus 3.2%), memory; CD45RA super(+)CD27 super(-) (43 plus or minus 6%), effector; and CD45RA super(-)CD27 super(-) (30 plus or minus 4.1%), memory/effector. The majority of tHLA super(+)CD8 super(+) T cells displayed an effector, CD27 super(-) phenotype (73%). However, few expressed perforin (17%). Epitope-specific in vitro stimulation (IVS) followed by 10-day expansion in IL-2 reversed this phenotype by increasing the number of perforin super(+) (84 plus or minus 3.6%; by paired t test, p < 0.001) and CD27 super(+) (from 28 to 67%; by paired t test, p = 0.01) tHLA super(+) T cells. This conversion probably represented a change in the functional status of tHLA super(+) T cells rather than a preferential expansion of a CD27 super(+) (naive and/or memory) PBMC, because it was reproduced after IVS of a T cell clone bearing a classic effector phenotype (CD45RA super(+)CD27 super(-)). These findings suggest that circulating vaccine-elicited T cells are not as functionally active as inferred by characterization of IVS-induced CTL. In addition, CD45RA/CD27 expression may be more informative about the status of activation of circulating T cells than their status of differentiation.</abstract></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5933-5942 |
issn | 0022-1767 |
language | eng |
recordid | cdi_proquest_miscellaneous_18398694 |
source | EZB Electronic Journals Library |
title | Functional Heterogeneity of Vaccine-Induced CD8 super(+) T Cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A05%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20Heterogeneity%20of%20Vaccine-Induced%20CD8%20super(+)%20T%20Cells&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Monsurro,%20V&rft.date=2002-06-01&rft.volume=168&rft.issue=11&rft.spage=5933&rft.epage=5942&rft.pages=5933-5942&rft.issn=0022-1767&rft_id=info:doi/&rft_dat=%3Cproquest%3E18398694%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_183986943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18398694&rft_id=info:pmid/&rfr_iscdi=true |